Clinical Trial Update: VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients [Phase 3]

View source ↗

Summary

The VERxVE Phase 3 trial compared Nevirapine XR to Nevirapine IR, each with Truvada, in treatment-naive HIV-infected patients; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Nevirapine IR (nevirapine)
• Nevirapine XR (nevirapine extended-release)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2012-01-19